NMR-based pharmacometabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment

José I. Serrano-Contreras, Isabel García-Pérez, María E. Meléndez-Camargo, Luis G. Zepeda-Vallejo

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

(±)-Venlafaxine, a bicyclic antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, is prescribed for the treatment of depression and anxiety disorders. As is the case with other antidepressants, its precise mechanisms of action are still unknown. Pharmacometabonomic approaches allow for the detection of diverse metabolites, unlike classic methods for analysing drug interaction based on single metabolites and linear pathways. This provides a global view of the state of homeostasis during treatment and an insight into the mechanisms of action of a drug. Accordingly, the final outcome of treatment is characterised by the network of reactome pathways derived from the on-target and off-target effects of the drug. Regarding antidepressants, the drug network may be located in the gut-microbiome-brain-liver-kidney-immune-cardiovascular system axis (GMBLKICA), implying that neurotransmitters participate as signalling molecules in bidirectional communication. If their bioavailability is increased, this communication and the state of homeostasis may be disrupted. With a pharmacometabonomic approach using NMR in combination with different chemometric methods, a determination was made of subtle changes in the metabolic profile (metabotype) of urine and faeces in normal Wistar rats following a single administration of pharmacological doses of (±)-venlafaxine hydrochloride. Based on the drug-response metabotypes observed, (±)-venlafaxine had effects on gut microbial co-metabolites and osmolytes. Hence, it can be hypothesized that bidirectional communication in the multiorgan axis was perturbed by this drug, and very likely by its active metabolite, (±)-desvenlafaxine. This disrupted signalling could be related not only to therapeutic and adverse effects, but also to the lag period in treatment response.

Original languageEnglish
Pages (from-to)82-92
Number of pages11
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume123
DOIs
StatePublished - 10 May 2016

Keywords

  • (±)-Venlafaxine
  • Gut microbial co-metabolite
  • Multiorgan axis
  • Multivariate data analysis
  • NMR-based pharmacometabonomics
  • Xenometabolome

Fingerprint

Dive into the research topics of 'NMR-based pharmacometabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment'. Together they form a unique fingerprint.

Cite this